Literature DB >> 29450509

Screening for Ovarian Cancer in Asymptomatic Women.

Karen H Lu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29450509     DOI： 10.1001/jama.2017.21894

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

Review 1.  Serum Biomarker Based Algorithms in Diagnosis of Ovarian Cancer: A Review.

Authors:  Suchitra Kumari
Journal:  Indian J Clin Biochem       Date:  2018-08-06

2.  Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma.

Authors:  Jeffrey D Krimmel-Morrison; Talayeh S Ghezelayagh; Shenyi Lian; Yuezheng Zhang; Jeanne Fredrickson; Daniela Nachmanson; Kathryn T Baker; Marc R Radke; Enna Hun; Barbara M Norquist; Mary J Emond; Elizabeth M Swisher; Rosa Ana Risques
Journal:  Gynecol Oncol       Date:  2019-12-12       Impact factor: 5.482

3.  Circular RNA CDR1as acts as a sponge of miR-135b-5p to suppress ovarian cancer progression.

Authors:  He Chen; Min Mao; Jing Jiang; Daling Zhu; Peiling Li
Journal:  Onco Targets Ther       Date:  2019-05-17       Impact factor: 4.147

4.  Hyperamylasemia may indicate the presence of ovarian carcinoma: A case report.

Authors:  Song Guo; Hongtao Lv; Li Yan; Fengnian Rong
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

5.  Proline-rich protein 11 overexpression is associated with a more aggressive phenotype and poor overall survival in ovarian cancer patients.

Authors:  Yu Zhan; Xueyuan Wu; Gang Zheng; Jingjing Jin; Chaofu Li; Guanzhen Yu; Wenfeng Li
Journal:  World J Surg Oncol       Date:  2020-12-04       Impact factor: 2.754

6.  Low Expression of Circular RNA hsa_circ_0078607 Predicts Poor Prognosis in High-Grade Serous Ovarian Cancer.

Authors:  Nan Zhang; Zhiyou Yang; Yue Jin; Shanshan Cheng; Jiani Yang; Yu Wang
Journal:  Cancer Manag Res       Date:  2021-03-29       Impact factor: 3.989

7.  MicroRNA-409-5p inhibits cell proliferation, and induces G2/M phase arrest and apoptosis by targeting DLGAP5 in ovarian cancer cells.

Authors:  Weiwei Li; Ji Lin; Jianfen Huang; Zhuoying Chen; Qunying Sheng; Fang Yang; Xue Yang; Xiaojie Cui
Journal:  Oncol Lett       Date:  2022-06-14       Impact factor: 3.111
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.